# Candida_auris: Supplemental information on *Candida auris* reference genome patches, current state-of-the-art and best-practice recommendations

If referencing this resource, please cite:\
(1) Alejandro R. Gener and Peera Hemarajata. "Status of public Candida auris whole genome assemblies." American Society 
of Microbiology Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines. Baltimore, 
Maryland. 16-19 October 2022.\
(2) Alejandro R. Gener. "Supplemental information on *Candida auris* reference genome patches, current state-of-the-art 
and best-practice recommendations." 16 Occtober 2022. https://github.com/GenerGener/Candida_auris.

# *Candida auris* exhibits high structural variability between clades

[Clade I vs. Clade II](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_003013715.2/GCA_016772135.1/21335/498019#)\
[Clade I vs. Clade III](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772135.1/GCA_016772215.1/21295/498019#)\
[Clade I vs. Clade IV](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772135.1/GCA_016772155.1/21315/498019#)\
[Clade I vs. Clade V](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772135.1/GCA_016809505.1/21345/498019#)\
[Clade II vs. Clade III](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_003013715.2/GCA_016772215.1/21255/498019#)\
[Clade II vs. Clade IV](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_003013715.2/GCA_016772155.1/21325/498019#)\
[Clade II vs. Clade V](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_003013715.2/GCA_016809505.1/21265/498019#)\
[Clade III vs. Clade IV](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772155.1/GCA_016772215.1/21305/498019#)\
[Clade III vs. Clade V](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772215.1/GCA_016809505.1/21275/498019#)\
[Clade IV vs. Clade V](https://ncbi.nlm.nih.gov/genome/cgv/browse/GCA_016772155.1/GCA_016809505.1/21285/498019#)

# Acknowledgements

Thanks to C. auris working group made up of CDC MDB, State and local PHLs, and the folks at Theiagen.

Special thanks to the development team (Sanjida Rangwala, Joel Virothaisakun, and Valerie Schneider) at NCBI working on 
the Comparative Genome Viewer (CGV) (https://ncbi.nlm.nih.gov/genome/cgv). CGV was developed as part of the NIH Comparative 
Genomics Resource (CGR), a National Library of Medicine project to establish an ecosystem to facilitate reliable comparative 
genomics analyses for all eukaryotic organisms.

**Funding:** 
This work was supported by Cooperative Agreement Number NU60OE000104-02 funded by the Centers for Disease Control 
and Prevention through the Association of Public Health Laboratories, and US CDC Epidemiology and Laboratory Capacity (ELC) 
for Infectious Diseases grant (6 NU50CK000498) to Los Angeles County. Its contents are solely the responsibility of the 
authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the 
Association of Public Health Laboratories. 

**Conflicts of interest statement:**
ARG received poster bursaries from Oxford Nanopore Technologies (UK) in 2019. ARG is on the editorial board of *AIDS*
